Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
dorsaVi Limited ( (AU:DVL) ) has shared an update.
dorsaVi has announced a five-year sales agreement with Select Medical, a leading US-based network of outpatient physical therapy centers, to offer its FDA-approved products across over 1,900 locations. This partnership follows an 18-month development pilot that ensured the technology met therapists’ needs, focusing on rehabilitation and return-to-play assessments for injured athletes. The agreement marks a significant opportunity for dorsaVi to enhance its presence in the US market, potentially impacting patient assessment and rehabilitation practices.
More about dorsaVi Limited
dorsaVi Ltd is an ASX-listed company specializing in innovative motion analysis device technologies for clinical applications, elite sports, and occupational health and safety. Their wearable sensor technology allows detailed human movement and position to be accurately captured and assessed outside a biomechanics lab in real-time and real situations for up to 24 hours.
Average Trading Volume: 6,464,599
Technical Sentiment Signal: Buy
Current Market Cap: A$50.64M
See more insights into DVL stock on TipRanks’ Stock Analysis page.